Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity

Cory Allen, Sompong Vongpunsawad, Takafumi Nakamura, C. David James, Mark Schroeder, Roberto Cattaneo, Caterina Giannini, James Krempski, Kah Whye Peng, Jenny M. Goble, Joon H. Uhm, Stephen J. Russell, Evanthia Galanis*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

92 Scopus citations

Fingerprint

Dive into the research topics of 'Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity'. Together they form a unique fingerprint.

Immunology and Microbiology

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology